Back to mobile site

More on PNGAF

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(OP:PNGAF)
Delayed: 0.34 -0.02 (5.56%)
Prev. Close $0.36  
Open$0.34 
52 Wk High$ 
52 Wk Low$ 
Day High$0.34 
Day Low$0.34 
P/E N/A  
EPS$ 
Volume15,000 

Friends, Peers and Foes (?): (more...)

Jun 11, 2026 05:02 PM Precision Peptide Company plans up to $2 million private placement
Jun 11, 2026 05:02 PM The Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common Shares
Jun 9, 2026 07:32 AM The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership
Jun 5, 2026 07:32 AM The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC
Jun 2, 2026 07:02 AM Precision Peptide signs US compounding pharmacy agreement
Jun 2, 2026 07:02 AM The Precision Peptide Company Inc. Signs Agreement with U.S.-Based 503A Sterile Compounding Pharmacy - Peptides to be 100% Compounded in the United States
May 28, 2026 07:32 AM The Precision Peptide Company to Exhibit as the Only Peptide Company at Dave Asprey's BEYOND Conference in Austin, Texas
May 26, 2026 07:32 AM The Precision Peptide Company Inc. Places Order for 20,000 BPC-157 Transdermal Patches
May 21, 2026 07:32 AM The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA)
May 19, 2026 07:02 AM Precision Peptide's BPC-157 patch achieves 95.5% purity in lab tests
View All Articles

Entities mentioned with PNGAF

View All Entities